期刊文献+

高效液相色谱-质谱联用法测定人血浆中奥昔布宁的浓度 被引量:3

Determination of oxybutynin in human plasma by HPLC-MS
下载PDF
导出
摘要 目的 建立一种用高效液相色谱 电喷雾离子化质谱联用技术测定奥昔布宁血药浓度的方法。方法 以 0 .0 1mol/L乙酸铵水溶液 甲醇 ( 15∶85 )为流动相 ,盐酸非洛普为内标 ,血浆样品经用环己烷萃取后上样 ,经C18柱分离后 ,以质谱为检测器 ,采用选择性离子检测 (SIM)测定人体血浆中奥昔布宁的浓度。结果 线性范围 0 .2~ 5 0ng/mL(r=0 .994 8) ,平均相对回收率在 90 %~ 110 %之间 ,日内和日间精密度的RSD均小于 10 % ,奥昔布宁的定量限为 0 .2ng/mL ,提取回收率大于 90 %。 结论 该方法快速、准确、灵敏 ,可用于奥昔布宁的药代动力学研究。 OBJECTIVE To develop a HPLC ESI MS method for determination of oxybutynin in human plasma. METHOD The mobile phase was composed of 0.01mol/L ammonium acetate/water: methanol(15:85),phenoprolamine hydrochloride was used as internal standard. Plasma samples were extracted with cyclohexane and separated by C 18 column. The single quadrapole MS was used as detector. SIM was used for determination of oxybutynin in human plasma.RESULTS Standard curve was linear in the range of 0.2 to 50 ng/mL( r =0.9948),the relative recovery was between 90%~110%. RSD of intra day and inter day assays were all less than 10%. The limit of detection was 0.2ng/mL. The extraction recovery was more than 90%.CONCLUSION The method developed is stable and reliable for determination of oxybutynin in human plasma as well as for pharmacokinetic studies.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2003年第6期479-481,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 高效液相色谱-质谱联用 奥昔布宁 药代动力学 HPLC MS oxybutynin pharmacokinetics
  • 相关文献

参考文献2

  • 1Yarker YE,Goa KL,Fitton A . Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability[J]. Drugs Aging,1995,6(3):243.
  • 2Patrick KS,Markowitz JS,Jarvi EJ,et al. Gas chromatographic-mass spectrometric analysis of plasma oxybutynin using a deuterated internal standard[J]. J of Chromatography (Bionmedical Application),1989,487:91.

同被引文献31

  • 1温清,贺坤,郭瑞臣.盐酸奥昔布宁临床应用进展[J].中国药事,2004,18(7):445-447. 被引量:7
  • 2钟大放.以加权最小二乘法建立生物分析标准曲线的若干问题[J].药物分析杂志,1996,16(5):343-346. 被引量:581
  • 3Yarker YE, Goa KL, Fit-ton A. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability [J]. Drugs Aging, 1995, 6 (3) : 243-62.
  • 4Zobrist RH, Schmid B, Feick A, et al. Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N- desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers[J]. Pharm Res, 2001, 18(7) : 1029-1034.
  • 5Kim H, Han SB. Sensitive determination of oxybutynin and desethyloxybutynin in dog plasma by LC-ESI/MS/MS [J]. J Pharm BiomedAnal, 2003, 31 (2) : 341-349.
  • 6Zobrist RH, Quan D, Thomas HM, et al. Pharmacokinetics and metabolism of transdermal oxybutynin: in vitro and in vivo performance of a novel delivery system [J]. Pharm Res, 2003, 20 (1) : 103-109.
  • 7Staskin DR, Robinson D. Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder [J]. Expert Opin Pharmacother, 2009, 10(18) : 3103-3111.
  • 8Patrick KS, Markowitz JS, Jarvi EJ, et al. Gas chromato graphicmass spect rom etric analysis of plasma oxybutynin using a deuterat ed internal standard [J]. J Chromat Ography (Bionmedical Application) , 1989, 487 (1): 91-98.
  • 9Matuszewski BK, Constanzer ML, Chavez-Eng CM, et al. Strategies for the assessment of matrix effect in quantitative bio-analytical methods based on HPLC-MS/MS [J]. Anal Chem, 2003, 75 (13): 3019-3030.
  • 10张文鼎,仇益群,黄仲义,董克权,刘任,方玉华.奥昔布宁对下尿路刺激症及急迫性尿失禁病人的疗效[J].新药与临床,1997,16(3):146-148. 被引量:3

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部